Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
SPI Energy Co Ltd ADR

Start price
Target price
Perf. (%)
€10.00
€12.00
0.00%

Risky Investment
High valuation
Revenue decline/stagnation expected
EBIT decline/stagnation expected
buy
Walt Disney Co.

Start price
Target price
Perf. (%)
€125.38
€130.00
1.60%

EBIT growth > 30% per year expected
Undervalued
Very high dividend yield expected
Top Rating
Las Vegas Sands Corp.

Start price
Target price
Perf. (%)
€48.89
-
-0.12%

Revenue decline/stagnation expected
EBIT decline/stagnation expected
Higher risks for its business
buy
Nel ASA

Start price
Target price
Perf. (%)
€2.17
€2.00
-1.34%

Could be very worthwhile Investment >20% year
Top Rating
Revenue growth > 30% per year expected
Leading role in innovation
buy
Soitec S.A.

Start price
Target price
Perf. (%)
€139.50
€145.00
0.93%

Could be very worthwhile Investment >20% year
Market Leader or Top 3
Well known brand
Very Future proof/growth oriented business model
Delivery Hero AG

Start price
Target price
Perf. (%)
€97.00
€70.00
-1.81%

Risky Investment
Junk rating
High risks in the balance sheet
buy
Novartis AG ADR

Start price
Target price
Perf. (%)
€74.00
€92.00
0.68%

buy
Elringklinger AG NA

Start price
Target price
Perf. (%)
€13.70
€15.00
2.77%

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Stable Large shareholder and/or long term investor
buy
Alfen

Start price
Target price
Perf. (%)
€76.00
€80.00
-10.00%

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Fair valuation
ROE higher than 10% per year
buy
ITM Power plc

Start price
Target price
Perf. (%)
€4.41
€5.00
-8.29%

buy
ITM Power plc

Start price
Target price
Perf. (%)
€4.30
€5.00
-6.05%

Could be worthwhile Investment >10% per year
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€442.80
€456.00
-3.85%

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
buy
Lenovo Group Ltd

Start price
Target price
Perf. (%)
€0.63
€0.000
-2.10%

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
buy
Varta AG

Start price
Target price
Perf. (%)
€114.50
€140.00
-4.54%

Could be very worthwhile Investment >20% year
buy
Paypal Holdings Inc

Start price
Target price
Perf. (%)
€163.80
€184.00
5.64%

Could be worthwhile Investment >10% per year
buy
StoneCo Ltd

Start price
Target price
Perf. (%)
€60.40
€188.00
0.07%

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Top 10 in its market
Very Future proof/growth oriented business model
buy
Varta AG

Start price
Target price
Perf. (%)
€114.60
-
-4.62%

Could be worthwhile Investment >10% per year
buy
Moderna Inc.

Start price
Target price
Perf. (%)
€85.27
€92.00
-2.84%

buy
NVIDIA Corp.

Start price
Target price
Perf. (%)
€441.70
-
-1.40%

Could be worthwhile Investment >10% per year
Revenue growth > 30% per year expected
EBIT growth >5% per year expected
Rising EBIT margin expected
Sony Corp

Start price
Target price
Perf. (%)
€76.39
-
-0.03%

EBIT growth >5% per year expected
Differentiated customer and product portfolio
Small cyclical dependencies
Revenue growth >5% per year expected
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€529.00
€450.00
-19.52%

Could be very worthwhile Investment >20% year
Very Future proof/growth oriented business model
Known brand
Market Leader or Top 3
buy
Bayer AG

Start price
Target price
Perf. (%)
€48.20
€78.00
1.30%

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Undervalued
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€529.00
€500.00
-19.52%

buy
Citizens Financial

Start price
Target price
Perf. (%)
€27.20
-
8.09%

Revenue growth >5% per year expected
EBIT decline/stagnation expected
Inovio Pharma

Start price
Target price
Perf. (%)
€8.95
-
-4.47%

Could be worthwhile Investment >10% per year
High risks for its business
Dependend from few customers or products